News Focus
News Focus
Followers 68
Posts 2915
Boards Moderated 0
Alias Born 04/22/2022

Re: JTORENCE post# 753289

Sunday, 03/09/2025 3:53:22 PM

Sunday, March 09, 2025 3:53:22 PM

Post# of 823603
J-To,



One crumb of evidence” might be found among the contract references on
page 28 of the recent SEC filing.

Although details are not publicly available yet, we might speculate that “deals” including research collaborations could have been inked with Oncovir, AIM ImmunoTech, and/or any of the companies that make PD-1 drugs. This is a reasonable evidence-based possibility because NWBO’s DC platforms are currently in PII combo trials with pembrolizumab and Ampligen®, and the Hiltonol combo study has concluded and was peer-reviewed.

Another “crumb” can be found around timestamp -1:03 of the ASM recording linked below:


We have been quietly in-licensing quite a number of different pieces of technology… We also have been putting some collaborations in place …we have not announced those yet…


https://nwbio.com/audio-of-nwbio-2023-annual-shareholders-meeting/








https://www.sec.gov/ix?doc=/Archives/edgar/data/1072379/000141057824001879/nwbo-20240930x10q.htm


https://www.nature.com/articles/s41467-024-48073-y

Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News